Tilray Brands, Inc. (TLRY)

↓ Download CSV

CIK 0001731348 · Nasdaq · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Fiscal year ends May 31

In fiscal 2025, Tilray Brands, Inc. reported revenue of $821.31M, up 4.1% from the prior year. The company ran a net loss, with a net margin of -266.3% and a gross margin of 29.3%. It held $2.07B in total assets against $584.75M in total liabilities.

Key ratios (FY2025)

29.3%
Gross margin
-277.9%
Operating margin
-266.3%
Net margin
-144.7%
Return on equity
+4.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$821.31M$788.94M$627.12M$628.37M$513.09M$405.33M$179.30M
Cost of Revenue$580.74M$565.59M$480.16M$511.56M$389.90M$185.83M$190.47M$28.86M
Gross Profit$240.57M$223.35M$146.96M$116.82M$123.18M$24.66M-$23.50M$14.28M$11.38M$2.67M
Operating Income-$2.28B-$174.75M-$1.37B-$610.40M-$132.17M-$201.12M-$304.14M-$57.84M-$7.50M-$7.05M
Net Income-$2.19B-$244.98M-$1.45B-$476.80M-$367.42M-$271.07M-$321.17M-$67.72M-$7.81M-$7.88M
EPS (Diluted)$-2.46$-0.33$-2.35$-0.99$-1.36$-0.47$-0.18
Total Assets$2.07B$4.22B$4.31B$5.45B$6.03B$945.95M$896.33M$656.67M$53.95M
Total Liabilities$584.75M$778.49M$977.32M$1.01B$1.56B$572.05M$611.06M$459.01M$58.80M
Shareholders' Equity$1.51B$3.44B$3.32B$4.40B$4.46B$373.90M$285.27M$197.65M-$4.85M$2.53M
Cash & Equivalents$221.67M$228.34M$206.63M$415.91M$488.47M$189.70M$96.79M$487.25M$2.32M
Operating Cash Flow-$94.60M-$30.91M$7.91M-$177.26M-$44.72M-$129.35M-$258.06M-$46.25M-$6.00M-$3.32M
Capital Expenditures$32.92M$29.25M$20.80M$34.06M$38.87M$98.79M$155.75M
Shares Outstanding890.33M742.65M617.98M481.22M269.55M216.16M203.46M